Please note: some of this content was published before July 1 2022. The Health and Care Act 2022 introduced significant changes to how the NHS in England is organised and these may not be reflected below.
Patient Group Directions (PGDs) provide a legal framework that allows some registered health professionals to supply and/or administer specified medicines to a pre-defined group of patients, without them having to see a prescriber (such as a doctor or nurse prescriber).
Supplying and/or administering medicines under PGDs should be reserved for situations in which this offers an advantage for patient care, without compromising patient safety. The PGDs that can be accessed via this page have been authorised by NHS England for use in/by services commissioned within South Yorkshire and Bassetlaw, West Yorkshire and North Yorkshire and the Humber.
PGD templates listed on the PHE imms.gov.uk website must not be used as these have not been authorised and are therefore not legal documents.
You can read more about PGDs on the National Institute for Health and Care Excellence (NICE) website.
PGDs for use in South Yorkshire and Bassetlaw, West Yorkshire and North Yorkshire and the Humber
The following PGDs have been produced to support all of the NHS immunisation programmes:
Download Flu Frequently Asked Questions & Answers 23/24 – Version 3: Last updated on 22 September 2023
|Inactivated influenza||Inactivated Influenza||01/04/24|
|Live Attenuated Influenza Vaccination||Fluenz® Tetra||01/04/24|
|National protocol for inactivated influenza vaccine||National protocol for inactivated influenza vaccine||01/04/24|
|Vaccine||PGD||Expiry||Newly authorised version*|
|DTaP/IPV or dTaP/IPV||Repevax®, Boostrix®-IPV||01/11/25||N/A|
|Hepatitis A||Hepatitis A (inactivated)||31/10/26||N/A|
|Hepatitis A & B||Twinrix® Adult, Twinrix® Paediatric, Ambirix®||31/10/26||N/A|
|Hepatitis A with typhoid||ViATIM®||28/02/24||N/A|
||Engerix B® HBvaxPRO®||30/04/25||N/A|
|Hepatitis B – for renal patients||Fendrix® HBvaxPRO® Engerix B®||30/04/25||N/A|
|HPV (GBMSM)||Gardasil® 9||01/09/25||N/A|
|Men ACWY||Menveo, Nimenrix, MenQuadfi||31/07/25||N/A|
|Men ACWY for risk groups||Menveo®, Nimenrix®, MedQuadfi® for risk groups||28/02/25||N/A|
|MenB for at risk groups||Bexsero®||28/02/25||N/A|
|Pneumococcal||Pneumovax® 23 (PPV23)||01/09/24||N/A|
|Pneumococcal for risk groups||Prevenar® 13 for Risk Groups||28/02/24||N/A|
|BCG||BCG vaccine AJV||31/08/26||N/A|
* Newly authorised versions are only provided for information to facilitate planning and authorisation and the active version should always be used up to the point at which it expires.
The gov.uk immunisation collection provides a wide variety of information and resources, including:
- Immunisation training resources for healthcare professionals
- Vaccine programmes
- Immunisation publications
- Immunisation leaflets and guidance for parents
- Vaccine handling and protocols
- Frequently asked questions (FAQs) for a range of programmes/vaccines
Specific resources can be found via the following links:
- The Green Book
- Routine immunisation schedule
- Individuals with uncertain or incomplete immunisation status
- Focus on travel immunisation
- Focus on hepatitis B immunisations
- Vaccinations and immunisation guidance
The following travel vaccines are also available but these are not covered by the NHS and so are not currently covered by an NHS England or PHE PGD. Vaccines for this purpose should given as a private service not be supplied using an FP10 or claimed for as a personally administered item.
- Hepatitis B (when not combined with hepatitis A) * 2 – See exceptions below
- Japanese encephalitis and tick-borne encephalitis
- Tuberculosis (TB)
- Yellow Fever
- *1 Hepatitis A & B Vaccine – Use restricted to areas endorsed by CCG – Harrogate and Rural District CCG & Hambleton, Richmondshire and Whitby CCG have decommissioned the combination Hepatitis A and B vaccine for travel purposes. Contact Medicines Management
- *2 Hepatitis B (when not combined with hepatitis A) – Sheffield CCG permit this for travel for certain indications. Check with CCG Medicines Management